Elinzanetant greatly decreases the occurrence and intensity of moderate to severe hot flashes tied to menopause.

programmed cell death protein 1 (PD-1) inhibitor carrelizumab and Rivoceranib in combination (hereinafter referred to as "Double Ai" combination) received a Complete Response Letter (CRL) from the FDA.

The occasion aimed to showcase preliminary data from Phase 1 trials of their innovative small molecule-drug conjugate (SMDC), VIP236.

On April 23, global biopharmaceutical company Incyte announced the finalization of an agreement to fully acquire clinical-stage drug development company Escient Pharmaceuticals.

Avacta Group plc announced that updated results from their Phase 1 clinical trial of the peptide drug conjugate AVA6000 were presented at the AACR.

5.13-5.19 Global Drug R&D Progress & Pharmaceutical Transaction Trends.

This collaboration aims to advance the Phase I/II clinical trials of TG4050, a personalized therapeutic vaccine for patients afflicted with head and neck cancers.

May 18th latest updates in the global new drug development field, including progress in new drug research and development, transaction information, and partnership developments.

The research focused on a trispecific antibody known as SAR441236, developed by ModeX Therapeutics Inc., a subsidiary of OPKO Health.

Elysium Therapeutics has made significant strides in enhancing opioid safety through the successful Phase 1 clinical trial of its O2P™ hydrocodone prodrug.

Grace Science, LLC has initiated a clinical trial for GS-100, a gene therapy developed to treat NGLY1 Deficiency, with the first patient receiving the treatment.

Ankyra Therapeutics has reached a pivotal moment with the commencement of patient dosing in a Phase 1 clinical trial for their drug candidate, ANK-101.